Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Sunday, June 18 • 8:30am - 12:00pm
#26: Smart, Innovative Risk-based Auditing: Shifting the Paradigm

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
Component Type: Tutorial
CE: CME 3.25; IACET 3.25; RN 3.25

Learn what regulators are looking for from sponsors and CROs as they initially assess their vendors and audit investigator sites for compliance and oversee them for compliance and quality throughout the clinical trial. As clinical trials become more complex involving additional data and vendors, why is it that companies keep using the traditional audit plan? As technology has provided the transparency and tools needed for trending, review and analytics, why is it that companies have yet to evolve to utilize them? Discuss various risk-based methodologies for audit programs and how logistical issues such as governmental travel advisories, environmental travel restrictions, resource issues (such as timing, budget) and availability of qualified individuals (auditors) may necessitate innovation to accomplish audit goals. Discuss case studies to assess risk in various remote auditing options which may provide a snapshot of compliance when travel may not be possible at that time and may assist in training auditors or providing subject matter expertise as needed from statisticians, IT professionals, etc. Learn methods for selecting what to audit and to what extent the auditing should be performed based on factors which may contribute to, or increase/decrease risk to subject safety and rights or data quality/integrity. Produce an audit plan that can be adapted for use to qualify (initial and re-qualification) and audit vendors (CROs, pharmacovigilance, eCOA vendors, etc.), study sites, and internal processes (when the department is off-site). Use the plan for auditing study site data, trial master files (TMF), databases, imaging data, etc.

Who should attend?

This short course is designed for:
  • Quality personnel from sponsor companies, CROs, and vendors
  • Data Managers, Clinical Operations, CRAs, Clinical Scientists, Medical Monitors and other project leaders with ideas on how and what critical to quality data should be presented to auditors
  • Representatives/ consultants of companies that provide auditing services

    Learning Objectives

    At the conclusion of this course, participants should be able to:
    • Determine which data is critical to quality using risk-based methodologies
    • Explore novel methods to access documents and data.
    • Develop more comprehensive and cross functional audit plans for oversight activities of vendors and CROs
    • New methods to host/ conduct a qualification, vendor, study site, or other GCP audits


Speakers
avatar for Joanne Malia

Joanne Malia

Associate Director, Clinical Documentation Management, Regeneron Pharmaceuticals
Joanne Malia is currently the Associate Director of Clinical Documentation Management at Regeneron, a biopharmaceutical company located in Tarrytown, NY. She has worked in clinical research at various global biotech, device, CRO and big pharma companies in the areas of quality... Read More →
avatar for Sarah Ann Silvers

Sarah Ann Silvers

Director, GCP Process Control and Compliance, Ce3
Sarah currently holds the title Director, GCP Process Control and Compliance and is charged with overseeing the Clinical Quality Program at Ce3 Inc. and its affiliate Cd3, a biometrics service provider. Among other responsibilities in this position Sarah designs, leads, and condu... Read More →


Sunday June 18, 2017 8:30am - 12:00pm
S404bc McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  • format json
  • Credit Type CME, IACET, RN
  • Tags Tutorial